Hope for Age Related Macular Degeneration with Lucentis希望為年齡相關性黃斑變性與Lucentis藥物
Saturday, December 31st, 2005 週六, 2005年12月31日 Genentech Inc. has applied for US (FDA) approval to market its drug Lucentis for the treatment of wet, age-related macular degeneration, the leading causes of blindness in the elderly. Genentech宣布已申請美國( FDA )的審批,以市場及其藥物Lucentis藥物用於治療濕的,年齡相關性黃斑變性,還會導致老年失明的。
Share This分享此
































